David Drutz
CIK 1428764 · Executive Chairman and CMO · last filed 2024-08-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$218.9K
Companies
2
Total Filings
38
Lifetime Open-Market Net
$50.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALT | Director | 83,859 | $2.61 | $218.9K | -$35.8K | 21 | 2024-08-20 |
| Midatech Pharma US Inc. (DARA) Delisted | Executive Chairman and CMO | 0 | — | — | $85.7K | 17 | 2015-12-07 |
Recent Filings · Page 2 of 4
38 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-15 | ALT | Exer (M) | +139 | $334 | EDGAR |
| 2021-11-19 | ALT | Exer (M) | +70 | $168 | EDGAR |
| 2021-09-24 | ALT | Grant (A) | — | $0 | EDGAR |
| 2020-11-17 | ALT | Exer (M) | +60 | $144 | EDGAR |
| 2020-10-16 | ALT | Exer (M) | +16,850 | $0 | EDGAR |
| 2020-09-28 | ALT | Grant (A) | — | $0 | EDGAR |
| 2020-06-29 | ALT | Grant (A) | — | $0 | EDGAR |
| 2019-01-04 | ALT | Grant (A) | — | $0 | EDGAR |
| 2017-10-17 | ALT | Grant (A) | — | $0 | EDGAR |
| 2017-08-24 | ALT | Buy (P) | +10,000 | $22.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.